Immunogenicity assay supporting clinical development of RGB-19, a proposed biosimilar to RoActemra®

Authors

Institutions

Publication Details

Journal
Bioanalysis
Published
2025-12-02
DOI
https://doi.org/10.1080/17576180.2025.2601872
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunogenicity assay supporting clinical development of RGB-19, a proposed biosimilar to RoActemra®

Katsuaki Nagasawa, Kazuya Uchida, János Pál Tóth, Attila Kónya
Bioanalysis
Biosimilars and Bioanalytical Methods
article

Immunogenicity assay supporting clinical development of RGB-19, a proposed biosimilar to RoActemra®

Katsuaki Nagasawa, Kazuya Uchida, János Pál Tóth, Attila Kónya
article en

Abstract

No abstract available for this paper.
BioanalysisVol. 17(23)
Mochida Pharmaceutical (Japan) (JP), Gedeon Richter (Hungary) (HU)
Openalex Percentile: Top 54%
Biosimilars and Bioanalytical Methods
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Immunogenicity assay supporting clinical development of RGB-19, a proposed biosimilar to RoActemra® — Katsuaki Nagasawa, Kazuya Uchida, et al. · Bioanalysis (2025) | TGRS Research Map | TGRS